| Target and Pathway |
Top |
| Target(s) |
ADAM metallopeptidase 33 (ADAM33) |
Target Info
|
Inhibitor |
[1] |
| Alpha-galactosidase A (GLA) |
Target Info
|
Inhibitor |
[1] |
| Antithrombin-III (ATIII) |
Target Info
|
Inhibitor |
[1] |
| Beta-2-glycoprotein 1 (APOH) |
Target Info
|
Inhibitor |
[1] |
| Cathepsin D (CTSD) |
Target Info
|
Inhibitor |
[1] |
| Cholinesterase (BCHE) |
Target Info
|
Inhibitor |
[1] |
| Cytotoxic T-lymphocyte protein 4 (CTLA-4) |
Target Info
|
Inhibitor |
[1] |
| Deoxyribonuclease I (DNASE1) |
Target Info
|
Inhibitor |
[1] |
| Dipeptidyl peptidase 4 (DPP-4) |
Target Info
|
Inhibitor |
[1] |
| Glycoprotein hormones alpha (CGA) |
Target Info
|
Inhibitor |
[1] |
| Heparin cofactor II (SERPIND1) |
Target Info
|
Inhibitor |
[1] |
| Immunoglobulin epsilon Fc receptor gamma (FCERG) |
Target Info
|
Inhibitor |
[1] |
| Influenza Hemagglutinin (Influ HA) |
Target Info
|
Inhibitor |
[1] |
| Influenza Neuraminidase (Influ NA) |
Target Info
|
Inhibitor |
[1] |
| Insulin-like growth factor I receptor (IGF1R) |
Target Info
|
Inhibitor |
[1] |
| Interleukin 6 receptor (IL6R) |
Target Info
|
Inhibitor |
[1] |
| Lactase-phlorizin hydrolase (LCT) |
Target Info
|
Inhibitor |
[1] |
| Lactotransferrin (LTF) |
Target Info
|
Inhibitor |
[1] |
| Liver carboxylesterase (CES1) |
Target Info
|
Inhibitor |
[1] |
| Low-density lipoprotein receptor (LDL-R) |
Target Info
|
Inhibitor |
[1] |
| Membrane-associated lectin type-C (CD209) |
Target Info
|
Inhibitor |
[1] |
| Nitric-oxide synthase brain (NOS1) |
Target Info
|
Inhibitor |
[1] |
| Phospholipase A2 (PLA2G1B) |
Target Info
|
Inhibitor |
[1] |
| Prostaglandin G/H synthase 1 (COX-1) |
Target Info
|
Inhibitor |
[1] |
| Reticulon-4 receptor (RTN4R) |
Target Info
|
Inhibitor |
[1] |
| Rhodopsin (RHO) |
Target Info
|
Inhibitor |
[1] |
| T-cell surface antigen CD2 (CD2) |
Target Info
|
Inhibitor |
[1] |
|
BioCyc
|
Phospholipases
|
|
C20 prostanoid biosynthesis
|
|
Thyroid hormone biosynthesis
|
|
Citrulline-nitric oxide cycle
|
|
KEGG Pathway
|
Drug metabolism - other enzymes
|
|
Metabolic pathways
|
|
Other glycan degradation
|
|
Cell adhesion molecules (CAMs)
|
|
T cell receptor signaling pathway
|
|
Autoimmune thyroid disease
|
|
Rheumatoid arthritis
|
|
Complement and coagulation cascades
|
|
Neuroactive ligand-receptor interaction
|
|
GnRH signaling pathway
|
|
Ovarian steroidogenesis
|
|
Prolactin signaling pathway
|
|
Thyroid hormone synthesis
|
|
Glycerophospholipid metabolism
|
|
Ether lipid metabolism
|
|
Arachidonic acid metabolism
|
|
Linoleic acid metabolism
|
|
alpha-Linolenic acid metabolism
|
|
Ras signaling pathway
|
|
Vascular smooth muscle contraction
|
|
Pancreatic secretion
|
|
Fat digestion and absorption
|
|
Phototransduction
|
|
Rap1 signaling pathway
|
|
HIF-1 signaling pathway
|
|
FoxO signaling pathway
|
|
Oocyte meiosis
|
|
Endocytosis
|
|
PI3K-Akt signaling pathway
|
|
AMPK signaling pathway
|
|
Focal adhesion
|
|
Adherens junction
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Long-term depression
|
|
Progesterone-mediated oocyte maturation
|
|
Pathways in cancer
|
|
Transcriptional misregulation in cancer
|
|
Proteoglycans in cancer
|
|
Glioma
|
|
Prostate cancer
|
|
Melanoma
|
|
Galactose metabolism
|
|
Glycerolipid metabolism
|
|
Sphingolipid metabolism
|
|
Glycosphingolipid biosynthesis - globo series
|
|
Lysosome
|
|
Platelet activation
|
|
Serotonergic synapse
|
|
Cytokine-cytokine receptor interaction
|
|
Jak-STAT signaling pathway
|
|
Hematopoietic cell lineage
|
|
Non-alcoholic fatty liver disease (NAFLD)
|
|
Bile secretion
|
|
Toxoplasmosis
|
|
Hepatitis C
|
|
Sphingolipid signaling pathway
|
|
Tuberculosis
|
|
Protein digestion and absorption
|
|
Carbohydrate digestion and absorption
|
|
Arginine and proline metabolism
|
|
Calcium signaling pathway
|
|
Phagosome
|
|
Circadian entrainment
|
|
Salivary secretion
|
|
Alzheimer's disease
|
|
Amyotrophic lateral sclerosis (ALS)
|
|
Fc epsilon RI signaling pathway
|
|
Asthma
|
|
Measles
|
|
NetPath Pathway
|
TGF_beta_Receptor Signaling Pathway
|
|
TCR Signaling Pathway
|
|
FSH Signaling Pathway
|
|
IL2 Signaling Pathway
|
|
EGFR1 Signaling Pathway
|
|
Panther Pathway
|
Blood coagulation
|
|
Thyrotropin-releasing hormone receptor signaling pathway
|
|
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction
|
|
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade
|
|
Insulin/IGF pathway-protein kinase B signaling cascade
|
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
|
Muscarinic acetylcholine receptor 1 and 3 signaling pathway
|
|
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
|
|
Nicotinic acetylcholine receptor signaling pathway
|
|
CCKR signaling map ST
|
|
Pathwhiz Pathway
|
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone
|
|
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin
|
|
Sphingolipid Metabolism
|
|
Galactose Metabolism
|
|
Arachidonic Acid Metabolism
|
|
Lactose Degradation
|
|
Arginine and Proline Metabolism
|
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
|
Pathway Interaction Database
|
E2F transcription factor network
|
|
p75(NTR)-mediated signaling
|
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
|
Glypican 1 network
|
|
Glucocorticoid receptor regulatory network
|
|
Fc-epsilon receptor I signaling in mast cells
|
|
Visual signal transduction: Rods
|
|
Plasma membrane estrogen receptor signaling
|
|
SHP2 signaling
|
|
IGF1 pathway
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
Integrins in angiogenesis
|
|
Stabilization and expansion of the E-cadherin adherens junction
|
|
LKB1 signaling events
|
|
Ceramide signaling pathway
|
|
Direct p53 effectors
|
|
Validated nuclear estrogen receptor alpha network
|
|
Reactome
|
ROS production in response to bacteria
|
|
Amyloid formation
|
|
Axonal growth inhibition (RHOA activation)
|
|
CTLA4 inhibitory signaling
|
|
Intrinsic Pathway of Fibrin Clot Formation
|
|
Common Pathway of Fibrin Clot Formation
|
|
Androgen biosynthesis
|
|
Thyroxine biosynthesis
|
|
Hormone ligand-binding receptors
|
|
G alpha (s) signalling events
|
|
Acyl chain remodelling of PC
|
|
Acyl chain remodelling of PE
|
|
Acyl chain remodelling of PI
|
|
The canonical retinoid cycle in rods (twilight vision)
|
|
Inactivation, recovery and regulation of the phototransduction cascade
|
|
G alpha (i) signalling events
|
|
IRS-related events triggered by IGF1R
|
|
SHC-related events triggered by IGF1R
|
|
Glycosphingolipid metabolism
|
|
MAPK3 (ERK1) activation
|
|
MAPK1 (ERK2) activation
|
|
LDL-mediated lipid transport
|
|
Chylomicron-mediated lipid transport
|
|
Retinoid metabolism and transport
|
|
Collagen degradation
|
|
Metabolism of Angiotensinogen to Angiotensins
|
|
MHC class II antigen presentation
|
|
Cell surface interactions at the vascular wall
|
|
Nitric oxide stimulates guanylate cyclase
|
|
Fc epsilon receptor (FCERI) signaling
|
|
Role of LAT2/NTAL/LAB on calcium mobilization
|
|
FCERI mediated MAPK activation
|
|
FCERI mediated Ca+2 mobilization
|
|
FCERI mediated NF-kB activation
|
|
CD209 (DC-SIGN) signaling
|
|
WikiPathways
|
NRF2 pathway
|
|
Nuclear Receptors Meta-Pathway
|
|
Heroin metabolism
|
|
Irinotecan Pathway
|
|
Fluoropyrimidine Activity
|
|
Phase I biotransformations, non P450
|
|
Latent infection of Homo sapiens with Mycobacterium tuberculosis
|
|
Spinal Cord Injury
|
|
Vitamin D Receptor Pathway
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
Allograft Rejection
|
|
Costimulation by the CD28 family
|
|
Complement and Coagulation Cascades
|
|
Formation of Fibrin Clot (Clotting Cascade)
|
|
Metabolism of steroid hormones and vitamin D
|
|
Metabolism of amino acids and derivatives
|
|
Peptide hormone biosynthesis
|
|
FSH signaling pathway
|
|
TSH signaling pathway
|
|
Thyroxine (Thyroid Hormone) Production
|
|
GPCR ligand binding
|
|
GPCR downstream signaling
|
|
Glycerophospholipid biosynthesis
|
|
GPCRs, Class A Rhodopsin-like
|
|
Visual phototransduction
|
|
Regulation of Microtubule Cytoskeleton
|
|
Integrated Breast Cancer Pathway
|
|
Integrin-mediated Cell Adhesion
|
|
Senescence and Autophagy in Cancer
|
|
Insulin Signaling
|
|
Endochondral Ossification
|
|
Focal Adhesion
|
|
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
|
|
Apoptosis
|
|
Signaling Pathways in Glioblastoma
|
|
MicroRNAs in cardiomyocyte hypertrophy
|
|
Sphingolipid metabolism
|
|
Prostaglandin Synthesis and Regulation
|
|
Arachidonic acid metabolism
|
|
Phase 1 - Functionalization of compounds
|
|
Eicosanoid Synthesis
|
|
Selenium Micronutrient Network
|
|
SIDS Susceptibility Pathways
|
|
IL-6 signaling pathway
|
|
Differentiation Pathway
|
|
Interleukin-6 signaling
|
|
DNA Damage Response (only ATM dependent)
|
|
Statin Pathway
|
|
Wnt Signaling Pathway
|
|
Wnt Signaling Pathway and Pluripotency
|
|
Lipid digestion, mobilization, and transport
|
|
Oncostatin M Signaling Pathway
|
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
|
SREBP signalling
|
|
Folate Metabolism
|
|
Vitamin B12 Metabolism
|
|
Metabolism of carbohydrates
|
|
Cell surface interactions at the vascular wall
|
|
Monoamine Transport
|
|
Myometrial Relaxation and Contraction Pathways
|
|
Amyotrophic lateral sclerosis (ALS)
|
|
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
|
|
Alzheimers Disease
|
|
Effects of Nitric Oxide
|
|
Serotonin Transporter Activity
|
|
IL1 and megakaryotyces in obesity
|
|
Fc epsilon receptor (FCERI) signaling
|
